Astero Klabatsa

<i>In vivo</i> Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Peter W. Szlosarek, Astero Klabatsa, A. Pallaska et al. · Clinical Cancer Research · 2006 · 180 citations

Medicine, Cancer Biology, Oncology +17

The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma

Astero Klabatsa, Sugama Chicklore, Sally F. Barrington et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 70 citations · Full text

Medicine, Oncology, Radiology +14

Prognostic factors in mesothelioma

Jeremy Steele, Astero Klabatsa, Dean A. Fennell et al. · Lung Cancer · 2005 · 62 citations

Veterinary Medicine, Oncology, Pathology +12

Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM)

Astero Klabatsa, Michael Sheaff, Jeremy Steele et al. · Lung Cancer · 2005 · 52 citations

Medicine, Cancer Biology, Oncology +16

Resistance to HSP90 inhibition involving loss of MCL1 addiction

Sara Busacca, Edward Law, Ian Powley et al. · Oncogene · 2015 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16